van der Heijde D, Calin A, Dougados M, Khan M A, van der Linden S, Bellamy N
Department of Internal Medicine, University of Maastricht, The Netherlands.
J Rheumatol. 1999 Apr;26(4):951-4.
To select specific instruments for each domain of the core set for endpoints in ankylosing spondylitis (AS), we gathered all instruments described in the literature to assess the domains chosen as endpoints in AS and sent them to 43 members of the Assessments in Ankylosing Spondylitis (ASAS) Working Group. The following domains were taken into account: function, pain, spinal mobility, patient global assessment, morning stiffness, peripheral joints and entheses, acute phase reactants, x-ray spine, x-ray hips, fatigue. For each instrument the members were asked to judge if the instrument was feasible and relevant. If an instrument was judged to be not feasible or not relevant by more than 50% of the respondents the instrument was deleted from the list. These data were presented during an ASAS workshop and the final decisions were about which instruments to include in the core set. This process was repeated separately for the settings disease controlling antirheumatic therapy (DC-ART), symptom modifying antirheumatic drugs (SMARD) and physical therapy, and clinical record keeping. The response rate to the questionnaire was 72%. For each domain one or more instruments were selected, except for Entheses and Fatigue. The chosen instruments were similar for the 3 above settings. Core sets of specific instruments were selected for the OMERACT filter test for relevance and feasibility. For all these instruments the remaining aspects of the OMERACT filter (truth and discrimination) should be assessed by literature review and if needed by additional research. It is recommended to use these instruments in all research projects in AS.
为了为强直性脊柱炎(AS)核心结局指标集的每个领域选择特定的工具,我们收集了文献中描述的所有用于评估选定为AS结局指标领域的工具,并将其发送给强直性脊柱炎评估(ASAS)工作组的43名成员。考虑了以下领域:功能、疼痛、脊柱活动度、患者整体评估、晨僵、外周关节和附着点、急性期反应物、脊柱X光、髋关节X光、疲劳。对于每个工具,要求成员判断该工具是否可行且相关。如果超过50%的受访者认为某工具不可行或不相关,则将该工具从列表中删除。这些数据在ASAS研讨会上公布,最终决定了核心结局指标集中应包括哪些工具。针对疾病控制抗风湿治疗(DC-ART)、症状改善抗风湿药物(SMARD)和物理治疗以及临床记录保存等情况分别重复这一过程。问卷的回复率为72%。除附着点和疲劳外,每个领域都选择了一种或多种工具。对于上述三种情况,所选工具相似。选择了特定工具的核心结局指标集用于OMERACT滤过标准测试的相关性和可行性。对于所有这些工具,应通过文献综述评估OMERACT滤过标准的其他方面(真实性和区分度),如有必要,还需进行额外研究。建议在AS的所有研究项目中使用这些工具。